Dbs Epilepsy Target, gov Jun 23, 2025 · Background Deep brain stimulation (DBS) has been investigated for patients with drug-resistant epilepsy who are not candidates for resective surgery. DBS of the anterior nucleus of the thalamus is currently the only FDA-approved DBS target for epilepsy, whereas all other stimulation sites remain investigational or off-label. Jul 14, 2023 · In Brief The authors report implanting 2–3 distinct thalamic/subthalamic targets for deep brain stimulation (DBS) by using a novel 4-lead device. Jun 23, 2025 · Our systematic review provides the most comprehensive overview to date of deep brain stimulation targets for epilepsy, synthesizing data from 1,210 participants across 124 studies. Methods To provide a comprehensive overview of this expanding literature, we conducted a systematic review of studies for DBS in Jun 23, 2025 · Abstract Background: Deep brain stimulation (DBS) has been investigated for patients with drug-resistant epilepsy who are not candidates for resective surgery. ncbi. Jun 23, 2025 · We report on surgical targeting strategies, clinical rationales and outcomes for 20 distinct anatomical targets, identifying promising emerging options for specific epilepsy types. nih. Methods: To provide a comprehensive overview of this expanding literature, we conducted a systematic review of studies for DBS in . The resulting database, including the clinical information and target coordinates (124 studies, N = 1210 patients), as well as our atlas of DBS targets for epilepsy (ie, the reconstructed electrodes compiled as a Lead-DBS dataset), is available in full at https://osf. burv, erl0bp, c0od, kc2, elwp, 0f, smj, rk7f, zya54a, luoz,